GABA-mimetic compounds block haloperidol-induced hyperprolactinemia in rats.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000480:Alkynes; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D004298:Dopamine / Q000502:physiology; D004983:Ethanolamines / Q000494:pharmacology; D006220:Haloperidol / Q000037:antagonists & inhibitors*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009919:Orchiectomy; D010903:Pituitary Gland, Anterior / Q000502:physiology; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000494:pharmacology*
D000480:Alkynes; D000614:Aminocaproates; D004983:Ethanolamines; D005680:gamma-Aminobutyric Acid; C013785:4-amino-5-hexynoic acid; D011388:Prolactin; D007986:Luteinizing Hormone; C020619:ethanolamine O-sulfate; D000612:4-Aminobutyrate Transaminase; D006220:Haloperidol; D004298:Dopamine